drugset

drugset / Trial / NCT02691897

Melatonin's Effects on Treatment Of Diabetes Mellitus

NCT02691897 ↗

Phase 0 Unknown 60 enrolled Shiraz University of Medical Sciences

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to assess the efficacy and safety of melatonin in control of blood sugar in patients with type 2 diabetes mellitus (DM).

Timeline

Start: 2019-07
Primary completion: 2020-05
Completion: 2020-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Melatonin	Small molecule	3 mg	—

Indications